ENGN FY 2022 Earnings — enGene Holdings Inc. Revenue & Financial Results | Market Cap Arena

ENGNenGene Holdings Inc.

$359M

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$2M

Net Income

$30,726

EPS (Diluted)

$0.00

Cash Flow

Operating Cash Flow

-$18M

Free Cash Flow

-$18M

Stock-Based Comp.

$116,000

Balance Sheet

Total Assets

$132M

Total Liabilities

$5M

Stockholders' Equity

$127M

Cash & Equivalents

$314,151

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$2M	-$16M	+88.5%
Net Income	$30,726	-$23M	+100.1%